NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 22, 2025 $1.27 -1.71% $1.29 X 98.29% 0
Apr 21, 2025 $1.26 -3.74% $1.29 V 97.75% 1
Apr 21, 2025 $1.27 -2.77% $1.29 V 98.74% 2
Apr 14, 2025 $1.10 -2.87% $1.14 X 96.28% 0
Apr 14, 2025 $1.11 -1.80% $1.14 X 97.34% 0
Apr 10, 2025 $1.09 -3.10% $1.11 V 97.78% 1
Apr 10, 2025 $1.10 -1.94% $1.11 V 98.95% 2
Apr 8, 2025 $1.07 +3.06% $1.04 X 96.94% 0
Apr 8, 2025 $1.06 +1.91% $1.04 X 98.09% 0
Apr 7, 2025 $1.07 +2.96% $1.04 X 97.04% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE